ESC 365 - How to prevent cardiotoxicity of cancer therapies?

HFA Premium Access

How to prevent cardiotoxicity of cancer therapies?

Session: Cardio-oncology: a partnership between heart failure specialists and oncologists

Topic: Cancer/Cardiotoxicity

Speaker: Associate Professor C. Tocchetti (Naples, IT)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Associate Professor Carlo Gabriele Tocchetti

University of Naples Federico II, Naples (Italy)

6 presentations

1 follower

3 more presentations in this session

Cancer therapy - cardiovascular complications.

Speaker: Associate Professor D. Farmakis (Athens, GR)

The heart failure patient scheduled for chemotherapy.

Speaker: Doctor D. Cardinale (Milan, IT)

Setting up a cardio-oncology service.

Speaker: Professor T. Suter (Bern, CH)

Access the full session

Cardio-oncology: a partnership between heart failure specialists and oncologists

Speakers: Associate Professor C. Tocchetti, Associate Professor D. Farmakis, Doctor D. Cardinale, Professor T. Suter

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources